February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

You are reading our weekly Well+Being newsletter. Sign up here to get it delivered to your inbox every Thursday. This week, ...

Resisting the reality of chronic illness can lead to emotional distress. Acceptance, on the other hand, can open the door to ...

The U.S. will ban nearly all uses of the common industrial cleaning agent, trichloroethylene (TCE), this year—more than 50 ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.

Discover the immune-modulating and respiratory benefits of herbal and dietary supplements like eucalyptol, ginseng, Echinacea ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

With its impressive health profile, it’s hard to beat green tea, which many say is the healthiest beverage you can drink. If ...

Lecanemab is the result of a strategic research alliance between BioArctic and Eisai. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble ...